老年人肌少症与高血压的关系及研究进展

倩 张(内蒙古科技大学包头医学院，中国)
金娥 高(内蒙古自治区人民医院，中国)
晓艳 郝(内蒙古自治区人民医院，中国)

摘要

随着中国步入老龄化社会，老年高血压合并肌少症患者发病率在逐年增加甚至呈爆发式增长，已成为我国乃至世界上普遍的慢性疾病，严重影响了老年人的生活质量及身心健康，并给家庭和社会带来巨大的经济压力。作为增龄性疾病，高血压和肌少症之间的相关性已得到证实，本文就老年肌少症与高血压的关系及研究进展做一综述。

关键词

肌少症；高血压；老年人；机制；治疗

参考

Dennison E M, Sayer A A, Cooper C. Epidemiology of sarcopenia and insight into possible therapeutic targets[J]. Nature Reviews Rheumatology, 2017,13(6):340-347.

张燕,王海鑫,路秀文,等.肌少症的流行病学及影响因素研究[J].中国临床保健杂志,2022,25(5):583-588.

Cruz-Jentoft A J. Sarcopenia: what should a pharmacist know?[J]. Farmacia Hospitalaria, 2017,41(4): 543-549.

Choi Y, Cho J, No M H, et al. Re-setting the circadian clock using exercise against sarcopenia[J]. International Journal of Molecular Sciences, 2020,21(9):3106.

Jimenez-Gutierrez G E, Martínez-Gómez L E, Martínez-Armenta C, et al. Molecular Mechanisms of Inflammation in Sarcopenia: Diagnosis and Therapeutic Update[J]. Cells, 2022,11(15):2359.

Chung H, Jo Y, Ryu D, et al. Artificial-intelligence-driven

discovery of prognostic biomarker for sarcopenia[J]. Journal of

cachexia, sarcopenia and muscle, 2021,12(6):2220-2230.

吴兴利,周长喜,施伟伟,等.老年肌少症与常见慢病共病的研究进展[J].老年医学与保健,2020,26(1):154-158.

Wang Z, Chen Z, Zhang L, et al. Status of hypertension in China: results from the China hypertension survey, 2012–2015[J]. Circulation, 2018,137(22):2344-2356.

王增武.中国高血压流行和防治现状[J].中国心血管病研究,2022,20(8):673-678.

Yin J, Lu X, Qian Z, et al. New insights into the pathogenesis and treatment of sarcopenia in chronic heart failure[J]. Theranostics, 2019,9(14):4019.

Savini S, Bandini M, Sannino A. An improved, rapid, and sensitive ultra-high-performance liquid chromatography-high-resolution orbitrap mass spectrometry analysis for the determination of highly polar pesticides and contaminants in processed fruits and vegetables[J]. Journal of agricultural and food chemistry, 2019,67(9):2716-2722.

Drey M, Krieger B, Sieber C C, et al. Motoneuron loss is

associated with sarcopenia[J]. Journal of the American Medical

Directors Association, 2014,15(6):435-439.

Zhang X, Xie W, Chen L, et al. Blood Flow Restriction Training for the Intervention of Sarcopenia: Current Stage and Future Perspective[J]. Frontiers in Medicine, 2022.

Liu Z, Zhu C. Causal relationship between insulin resistance and sarcopenia[J]. Diabetology & Metabolic Syndrome, 2023,15(1):1-15.

Li C, Yu K, Shyh-Chang N, et al. Pathogenesis of sarcopenia and the relationship with fat mass: descriptive review[J]. Journal of Cachexia, Sarcopenia and Muscle, 2022,13(2):781-794.

Gungor O, Ulu S, Hasbal N B, et al. Effects of hormonal changes on sarcopenia in chronic kidney disease: where are we now and what can we do?[J]. Journal of cachexia, sarcopenia and muscle, 2021,12(6):1380-1392.

Gungor O, Ulu S, Hasbal N B, et al. Effects of hormonal changes on sarcopenia in chronic kidney disease: where are we now and what can we do?[J]. Journal of cachexia, sarcopenia and muscle, 2021,12(6):1380-1392.

Bartke A. Growth hormone and aging: updated review[J]. The World Journal of Men’s Health, 2019,37(1):19-30.

McKee A, Morley J E, Matsumoto A M, et al. Sarcopenia: an endocrine disorder?[J]. Endocrine Practice,2017,23(9):1143-1152.

Uchitomi R, Oyabu M, Kamei Y. Vitamin D and sarcopenia:

potential of vitamin D supplementation in sarcopenia prevention and treatment[J]. Nutrients, 2020,12(10):3189.

DOI: http://dx.doi.org/10.12345/yzlcyxzz.v6i5.12794